Comparative Assessment of Echocardiography and Magnetic Resonance Imaging in the Evaluation of Structural Cardiopathies in Adults: A Comprehensive Analysis

Main Article Content

Alejandro Arias Mendoza
Emelí Estrada Pérez
Francisco Vázquez Martin
Jessica Arlene Avalos
Mauricio Emmanuel Umaña Reyes
Teresa Jannete Ortega Valls

Abstract

Cardiovascular diseases, specifically structural cardiopathies, continue to pose a significant burden on global healthcare systems. The accurate assessment of these conditions in adults demands precise and reliable imaging modalities. This article presents a comprehensive exploration of the role of two prominent diagnostic tools, echocardiography and magnetic resonance imaging (MRI), in the evaluation of structural cardiopathies in the adult population. We scrutinize the clinical utility, advantages, limitations, and diagnostic accuracy of both imaging techniques, shedding light on their respective roles in the clinical decision-making process. Furthermore, we delve into recent advancements and emerging trends in echocardiography and MRI, highlighting the potential synergistic use of these modalities to optimize the diagnostic and therapeutic approach to structural cardiopathies in adults. The findings from this review will contribute to enhancing clinical practice and patient outcomes in the management of these intricate cardiovascular conditions.

Article Details

How to Cite
Alejandro Arias Mendoza, Emelí Estrada Pérez, Francisco Vázquez Martin, Jessica Arlene Avalos, Mauricio Emmanuel Umaña Reyes, & Teresa Jannete Ortega Valls. (2023). Comparative Assessment of Echocardiography and Magnetic Resonance Imaging in the Evaluation of Structural Cardiopathies in Adults: A Comprehensive Analysis. International Journal of Medical Science and Clinical Research Studies, 3(10), 2456–2460. https://doi.org/10.47191/ijmscrs/v3-i10-63
Section
Articles

References

I. Kamel H, Healey JS. Cardioembolic stroke. Circ Res. (2017) 120:514–26.

1161/CIRCRESAHA.116.308407

II. Doufekias E, Segal AZ, Kizer JR. Cardiogenic and aortogenic brain embolism. J Am Coll Cardiol. (2008) 51:1049–59. 10.1016/j.jacc.2007.11.053

III. McGrath ER, Paikin JS, Motlagh B, Salehian O, Kapral MK, O'Donnell MJ. Transesophageal echocardiography in patients with cryptogenic ischemic stroke: A systematic review. Am Heart J. (2014) 168:706–12.e14. 10.1016/j.ahj.2014.07.025

IV. Harris J, Yoon J, Salem M, Selim M, Kumar S, Lioutas VA. Utility of transthoracic echocardiography in diagnostic evaluation of ischemic stroke. Front Neurol. (2020) 11:103. 10.3389/fneur.2020.00103

V. Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al.. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke a guideline for healthcare professionals from the American Heart Association/American Stroke A. Stroke. (2019) 50:E344–418.

1161/STR.0000000000000211

VI. Yaghi S, Chang AD, Cutting S, Jayaraman M, McTaggart RA, Ricci BA, et al.. Troponin improves the yield of transthoracic echocardiography in ischemic stroke patients of determined stroke subtype. Stroke. (2018) 49:2777–9. 10.1161/STROKEAHA.118.022477

VII. Foreman B, Campbell C, Sosh D, Carter R, Lee V, Orsinelli D. The yield of transthoracic and transesophageal echocardiograms in ischemic stroke work-up. J Am Coll Cardiol. (2020) 75:1691. 10.1016/s0735-1097(20)32318-4

VIII. Takasugi J, Yamagami H, Noguchi T, Morita Y, Tanaka T, Okuno Y, et al.. Detection of left ventricular thrombus by cardiac magnetic resonance in embolic stroke of undetermined source. Stroke. (2017) 48:2434–40.

1161/STROKEAHA.117.018263

IX. Harloff A, Handke M, Reinhard M, Geibel A, Hetzel A. Therapeutic strategies after examination by transesophageal echocardiography in 503 patients with ischemic stroke. Stroke. (2006) 37:859–64. 10.1161/01.STR.0000202592.87021.b7

X. De Groot NMS, Schalij MJ. Imaging modalities for measurements of left atrial volume in patients with atrial fibrillation: what do we choose? Europace. (2010) 12:766–7. 10.1093/europace/euq140

XI. Herm J, Konieczny M, Jungehulsing GJ, Endres M, Villringer A, Malzahn U, et al.. Should transesophageal echocardiography be performed in acute stroke patients with atrial fibrillation? J Clin Neurosci. (2013) 20:554–9.

1016/j.jocn.2012.03.049

XII. Siebermair J, Kholmovski EG, Marrouche N. Assessment of left atrial fibrosis by late gadolinium enhancement magnetic resonance imaging: methodology and clinical implications. JACC Clin Electrophysiol. (2017) 3:791–802.

1016/j.jacep.2017.07.004

XIII. Fonseca AC, Alves P, Inácio N, Marto JP, Viana-Baptista M, Pinho-E-Melo T, et al.. Patients with undetermined stroke have increased atrial fibrosis: A cardiac magnetic resonance imaging study. Stroke. (2018) 49:734–7.

1161/STROKEAHA.117.019641

XIV. Weinsaft JW, Kim HW, Crowley AL, Klem I, Shenoy C, Van Assche L, et al.. LV thrombus detection by routine echocardiography: Insights into performance characteristics using delayed enhancement CMR. JACC Cardiovasc Imaging. (2011) 4:702–12. 10.1016/j.jcmg.2011.03.017

XV. Kim HW, Van Assche L, Jennings RB, Wince WB, Jensen CJ, Rehwald WG, et al.. Relationship of T2-weighted MRI myocardial hyperintensity and the ischemic area-at-risk. Circ Res. (2015) 117:254–65. 10.1161/CIRCRESAHA.117.305771

XVI. Jensen JK. Evaluating the role of elevated levels of troponin in acute ischemic stroke. Biomark Med. (2008) 2:457–64. 10.2217/17520363.2.5.457

Most read articles by the same author(s)